Antioxidant, hypolipidemic, and anti-angiotensin-1-converting enzyme properties of lemon (Citrus limon) and lime (Citrus aurantifolia) juices

被引：27

作者：

Oboh G. ^{[1
]}

Bello F.O. ^{[1
]}

Ademosun A.O. ^{[1
]}

Akinyemi A.J. ^{[1
]}

Adewuni T.M. ^{[1
]}

机构：

[1] Functional Foods and Nutraceutical Research Unit, Department of Biochemistry, Federal University of Technology, P.M.B. 704, Akure

来源：

Comparative Clinical Pathology | 2015年 / 24卷 / 6期

关键词：

Angiotensin-1-converting enzyme; Antioxidant; Cholesterol; Lemon; Lime;

D O I：

10.1007/s00580-015-2088-x

中图分类号：

学科分类号：

摘要：

Lemon (Citrus limon) and lime (Citrus aurantifolia) juices are used in folk medicine for the management of hypertension and other cardiovascular diseases, but the mechanism of action by which they exert their therapeutic action is unclear. The aim of this study is to investigate the effect of lemon and lime juices on angiotensin-1-converting enzyme (ACE) activity in vitro and investigate the hypocholesterolemic properties of the juices in a high-cholesterol diet rat model. The phenolic content and antioxidant properties of the manually squeezed juices were also determined. Lemon juice had higher total phenol content (64.5 mg/l), while lime juice had higher total flavonoid content (29.5 mg/l). Both juices inhibited ACE activity in a dose-dependent manner and also exhibited antioxidant activities as typified by their ferric reducing power, and radicals (DPPH·, ABTS·, OH·, and NO·) scavenging abilities, as well as inhibition of Fe2+- and sodium nitroprusside-induced lipid peroxidation in rat’s liver in vitro. Administration of the juices to rats fed with a high-cholesterol diet caused a significant reduction in plasma total cholesterol, triglyceride, and LDL-cholesterol levels and an increase in plasma HDL-cholesterol levels. The inhibition of ACE activity in vitro and in vivo hypocholesterolemic effect of the juices could explain the use of the juices in the management of cardiovascular diseases. © 2015, Springer-Verlag London.

引用

页码：1395 / 1406

页数：11

共 66 条

[1]

Actis-Goretta L., Ottaviani J.I., Keen C.L., Fraga C.G., Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins, FEBS Lett, 555, pp. 597-600, (2003)

[2]

Adefegha S.A., Oboh G., Adefegha O.M., Boligon A.A., Athayde M.L., Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model, J Sci Food Agric, 94, 13, pp. 2726-2737, (2014)

[3]

Ademosun A.O., Oboh G., Inhibition of acetylcholinesterase activity and Fe<sup>2+</sup>-induced lipid peroxidation in rat brain in vitro by some citrus fruit juices, J Med Food, 15, pp. 1-7, (2012)

[4]

Aherne S.A., O'Brien M.N., Dietary flavonols: chemistry, food content, and metabolism, Nutrition, 18, pp. 75-81, (2002)

[5]

Ahnfelt-Ronne I., Enzyme inhibitors as drugs, A textbook of drug design and development, pp. 302-307, (1991)

[6]

Austin M.A., Carolyn M.H., Zimmern R.L., Humphries S.E., Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Ame J Epidemiol 160, No. 5 Johns Hopkins Bloomberg School of Public Health U.S.A, doi:10.1093/aje/kwh237, (2004)

[7]

Aviram M., Modified forms of low-density lipoprotein and atherosclerosis, Atherosclerosis, 98, pp. 1-9, (1993)

[8]

Barter P., Gotto A.M., LaRosa J.C., Maroni J., Szarek M., Grundy S.M., Kastelein J.J., Bittner V., Fruchart J.C., Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, N Engl J Med, 57, pp. 1301-1310, (2007)

[9]

Belle N.A.V., Dalmolin G.D., Fonini G., Rubim M.A., Rocha J.B.T., Polyamines reduces lipid peroxidation induced by different pro-oxidant agents, Brain Res, 1008, pp. 245-251, (2004)

[10]

Benderitter M., Maupoil V., Vergely C., Dalloz F., Briot F., Rochette L., Studies by electron paramagnetic resonance of the importance of iron in hydroxyl scavenging properties of ascorbic acid in plasma: effects of iron chelators, Fundam Clin Pharmacol, 12, pp. 510-516, (1998)

← 1 2 3 4 5 6 7 →